Dashboard PDUFA PDUFA History Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free public preview Track GRCE with free AI briefings, catalyst countdowns, and dilution alerts.

GRCE — Grace Therapeutics, Inc.

FDA catalysts, PDUFA dates with approval probability, drug pipeline, cash runway and insider activity — updated automatically from SEC, FDA and ClinicalTrials.gov data.

📅 Past FDA Decisions & Stock Reactions

DateDrugTypeRun-up 30dDecision 1dAfter 5d
2026-04-23 NDA -2.7% -45.5% -51.3%
2025-08-22 NDA -1.5% -1.5% -9.4%

Browse all historical PDUFA outcomes →

Get the full GRCE picture

A free BioRadar account adds AI daily briefings, sentiment tracking, trial enrollment progress, and email alerts for GRCE and 2 more tickers of your choice.

Create Free Account →
Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.